PHARMACOKINETICS OF E-5-(2-BROMOVINYL)-2'-DEOXYURIDINE IN MICE

被引:28
作者
DECLERCQ, E [1 ]
DESCAMPS, J [1 ]
DESOMER, P [1 ]
BARR, PJ [1 ]
JONES, AS [1 ]
WALKER, RT [1 ]
机构
[1] UNIV BIRMINGHAM, DEPT CHEM, BIRMINGHAM B15 2TT, W MIDLANDS, ENGLAND
关键词
D O I
10.1128/AAC.16.2.234
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The pharmacokinetics of the newly developed anti-herpes agent, E-5-(2-bromovinyl)-2'-deoxyuridine, was compared with that of the standard anti-herpes drug 5-iodo-2'-deoxyuridine. Both compounds were administered to mice at 100 mg/kg by either the intraperitoneal, subcutaneous, or oral route. The active blood drug levels achieved by E-5-(2-bromovinyl)-2'-deoxyuridine were considerably higher than those attained by 5-iodo-2'-deoxyuridine (serum peak concentrations: 40 to 100 and 4 to 10 μg/ml, respectively). Active blood drug levels could still be found 320 min after oral administration of E-5-(2-bromovinyl)-2'-deoxyuridine.
引用
收藏
页码:234 / 236
页数:3
相关论文
共 4 条
  • [1] Bauer DJ, 1977, SPECIFIC TREATMENT V
  • [2] DECLERCQ E, 1979, P NATL ACAD SCI USA, V76, P2947, DOI 10.1073/pnas.76.6.2947
  • [3] HERPESVIRUS-HOMINIS INFECTION IN NEWBORN MICE .1. EXPERIMENTAL MODEL AND THERAPY WITH IODODEOXYURIDINE
    KERN, ER
    OVERALL, JC
    GLASGOW, LA
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1973, 128 (03) : 290 - 299
  • [4] 9-(2-HYDROXYETHOXYMETHYL)GUANINE ACTIVITY AGAINST VIRUSES OF HERPES GROUP
    SCHAEFFER, HJ
    BEAUCHAMP, L
    MIRANDA, PD
    ELION, GB
    BAUER, DJ
    COLLINS, P
    [J]. NATURE, 1978, 272 (5654) : 583 - 585